Sections
Shows
Events
Pfizer, Oxford COVID-19 vaccines reduces severity of the disease in elderly: pre-print study
Oxford-AstraZeneca COVID-19 vaccine will be available at cost price across world, says pharma head Olivier Nataf
Serum Institute gets DCGI nod to conduct phase 2, 3 human trials of Oxford vaccine in 1,600 healthy volunteers in India
Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine
